癫痫患者可穿戴设备的偏好与用户体验:系统综述与混合方法合成
本混合方法系统综述检索2000年1月1日至2021年5月26日的同行评议文献,纳入22项观察性研究、共3299名参与者,分析癫痫患者和照护者对可穿戴癫痫检测设备的偏好与体验。偏好包括改善照护、成本、准确性和设计,患者期望发作后≤15分钟实时检测、灵敏度≥90%且误报率低,设备成本<$300 USD、月订阅费<$20 USD更受青睐,手腕式设备接受度更高。
要点
- 患者期望发作后≤15分钟实时检测,灵敏度≥90%且误报率低。
- 设备成本<$300 USD和月订阅费<$20 USD是接受度的重要偏好。
- 手腕式设备在评估用户体验的研究中接受度更高。
核心结论
- 用户对癫痫发作检测可穿戴技术的接受度受准确性、设计、舒适度和成本的强烈影响。
- 研究强调需要标准化和经过验证的工具,利用本研究发现的主题全面检查该人群对可穿戴设备的偏好和用户体验。
- 需要更多努力将观点和用户体验纳入癫痫检测可穿戴设备的开发,特别是在社区环境中。
研究设计与样本
- 混合方法系统综述,检索2000年1月1日至2021年5月26日间同行评议的原创出版物。
- 共纳入22项观察性研究,合计3299名参与者的回应,包括癫痫患者、照护者和医疗工作者。
- 16项研究检查用户偏好,5项检查用户体验,1项同时检查体验和偏好。
主要发现
- 重要偏好包括改善照护、成本、准确性和设计。
- 患者期望发作后≤15分钟的实时检测,以及高灵敏度(≥90%)和低误报率。
- 设备成本<$300 USD和月订阅费<$20 USD更受偏好。
- 尽管癫痫猝死是可穿戴技术的主要驱动因素,但很少被讨论。
- 在评估用户体验的研究中,手腕式设备接受度更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To examine the preferences and user experiences of people with epilepsy and caregivers regarding automated wearable seizure detection devices. METHODS: We performed a mixed-methods systematic review. We searched electronic databases for original peer-reviewed publications between January 1, 2000, and May 26, 2021. Key search terms included "epilepsy," "seizure," "wearable," and "non-invasive." We performed a descriptive and qualitative thematic analysis of the studies included according to the technology acceptance model. Full texts of the discussion sections were further analyzed to identify word frequency and word mapping. RESULTS: Twenty-two observational studies were identified. Collectively, they comprised responses from 3,299 participants including patients with epilepsy, caregivers, and healthcare workers. Sixteen studies examined user preferences, 5 examined user experiences, and 1 examined both experiences and preferences. Important preferences for wearables included improving care, cost, accuracy, and design. Patients desired real-time detection with a latency of ≤15 minutes from seizure occurrence, along with high sensitivity (≥90%) and low false alarm rates. Device-related costs were a major factor for device acceptance, where device costs of <$300 USD and a monthly subscription fee of <$20 USD were preferred. Despite being a major driver of wearable-based technologies, sudden unexpected death in epilepsy was rarely discussed. Among studies evaluating user experiences, there was a greater acceptance toward wristwatches. Thematic coding analysis showed that attitudes toward device use and perceived usefulness were reported consistently. Word mapping identified "specificity," "cost," and "battery" as key single terms and "battery life," "insurance coverage," "prediction/detection quality," and the effect of devices on "daily life" as key bigrams. DISCUSSION: User acceptance of wearable technology for seizure detection was strongly influenced by accuracy, design, comfort, and cost. Our findings emphasize the need for standardized and validated tools to comprehensively examine preferences and user experiences of wearable devices in this population using the themes identified in this study. Greater efforts to incorporate perspectives and user experiences in developing wearables for seizure detection, particularly in community-based settings, are needed. TRIAL REGISTRATION INFORMATION: PROSPERO Registration CRD42020193565.
引用
- Sivathamboo S, Nhu D, Piccenna L, et al. Preferences and User Experiences of Wearable Devices in Epilepsy: A Systematic Review and Mixed-Methods Synthesis. Neurology. 2022. PMID: 35705497. doi:10.1212/WNL.0000000000200794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。